Topical beta-blocker may offer new option for feline angiomatosis

A rare feline footpad vascular lesion may have a new, less invasive treatment option. In a case report published in Veterinary Dermatology, Adrien Accard, Rita Bitar, and Maria Dolores Sanchez described a 5-year-old female cat with a slow, progressive purple lesion on a metatarsal pad that caused ulceration and pain and was diagnosed as cutaneous angiomatosis, a non-neoplastic vascular proliferation. The authors reported successful treatment with a topical beta-blocker, offering an alternative to the more aggressive approaches that have typically been described for these lesions. Prior veterinary case reports have often involved surgery, including complete pad resection or even limb amputation when local control was difficult. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this case points to a potentially useful medical option for a rare but challenging condition that can mimic more serious vascular disease and can be painful, recurrent, and hard to manage on distal limbs. Published veterinary literature has characterized cutaneous angiomatosis as a progressive vascular lesion in dogs and cats, with prior feline reports emphasizing surgery or laser photocoagulation rather than topical drug therapy. In human dermatology, topical beta-blockers such as timolol and propranolol have been used off-label across a growing list of vascular lesions, with reviews describing them as a generally well-tolerated addition to the dermatologic toolkit, though still supported mainly by case-based evidence. (pubmed.ncbi.nlm.nih.gov)

What to watch: Whether additional veterinary case reports or small series confirm efficacy, dosing, safety, and recurrence outcomes for topical beta-blockers in feline vascular lesions. (pubmed.ncbi.nlm.nih.gov)